Friday, November 13, 2026||
MultiKhabarMultiKhabar

Alkem PAT down at ₹675 crore; biotech sales down 37% on ‘lumpy’ CDMO business

Share:WhatsAppFacebookX (Twitter)Telegram
Alkem PAT down at ₹675 crore; biotech sales down 37% on ‘lumpy’ CDMO business
Photo / Coverage: The Hindu Business Line
EXECUTIVE SUMMARY

The company posted total revenue from operations at ₹4,552 crore, up 13.8% compared to the same period last year

Key Takeaways

  • Alkem PAT down at ₹675 crore; biotech sales down 37% on ‘lumpy’ CDMO business.

The company posted total revenue from operations at ₹4,552 crore, up 13.8% compared to the same period last year

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on The Hindu Business Line

Visit Publisher Site →

Related News

🇮🇳 India
Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play